A novel treatment option of bipolar depression with psychotic and catatonic features.
Di Michele
Vittorio
V
Bolino
Francesca
F
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy*; D002389:Catatonia / Q000150:complications* / Q000188:drug therapy; D002997:Clomipramine / Q000627:therapeutic use*; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D017374:Paroxetine / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000150:complications* / Q000188:drug therapy; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D014150:Antipsychotic Agents; D002997:Clomipramine; D003987:Dibenzothiazepines; D006220:Haloperidol; D008140:Lorazepam; D017374:Paroxetine; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors; D013566:Sympathomimetics